Evaluation of red blood cell distribution width in cats with hypertrophic cardiomyopathy by Stanzani, G et al.
  
RVC OPEN ACCESS REPOSITORY – COPYRIGHT NOTICE 
 
This is the peer-reviewed, manuscript version of the following article: 
Stanzani, G., Cowlam, R., English, K. and Connolly, D. J. (2015) 'Evaluation of red blood cell 
distribution width in cats with hypertrophic cardiomyopathy', Journal of Veterinary Cardiology, 
17, Supplement 1, S233-S243. 
 
The final version is available online via http://dx.doi.org/10.1016/j.jvc.2015.09.001.        
© 2015. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/. 
The full details of the published version of the article are as follows: 
 
TITLE: Evaluation of red blood cell distribution width in cats with hypertrophic 
cardiomyopathy 
AUTHORS: Stanzani, G., Cowlam, R., English, K. and Connolly, D. J. 
JOURNAL TITLE: Journal of Veterinary Cardiology 
VOLUME/EDITION: 17/Supplement 1 
PUBLISHER: Elsevier 
PUBLICATION DATE: December 2015 
DOI: 10.1016/j.jvc.2015.09.001 
Evaluation of Red Blood Cell Distribution Width in Cats with Hypertrophic Cardiomyopathy 1 
Authors: 2 
Giacomo Stanzania  DVM 3 
Rory Cowlama 4 
Kate Englisha  BSc BVetMed FRCPath 5 
David J Connollya  BSc BVetMed PhD CertVC CertSAM 6 
a Royal Veterinary College, Hawkshead Lane, Hatfield, Hertfordshire, UK, AL9 7TA 7 
Short title: RDW in cats with hypertrophic cardiomyopathy 8 
Corresponding author: 9 
Giacomo Stanzani, Clinical Science and Services, Royal Veterinary College, Hawkshead Lane, Hatfield, 10 
Hertfordshire, UK, AL9 7TA. E-mail: gstanzani@rvc.ac.uk 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
Abstract: 22 
Background: Red Blood Cell Distribution Width (RDW) is a measurement of variability in circulating 23 
erythrocytes volume and has recently been shown to correlate with prognosis in a variety of human diseases, 24 
including acute and chronic heart failure. 25 
Objective: To determine if RDW differs between healthy controls, cats with hypertrophic cardiomyopathy 26 
(HCM) without congestive heart failure (CHF) and cats with HCM and CHF and evaluate whether RDW values at 27 
presentation can provide useful prognostic information in cats with HCM. 28 
Animals: Retrospective single-centre study. Seventy-three cats diagnosed with HCM by echocardiography and 29 
30 healthy controls presented to a veterinary teaching hospital between October 2006 and April 2013 were 30 
included. Physical examination, haematology and echocardiographic data obtained on one single visit were 31 
retrospectively reviewed and compared between three groups: controls, cats with HCM without CHF and cats 32 
with HCM and CHF. Outcome data was obtained from clinical records or referring veterinarians. Univariable 33 
and multivariable survival analyses were performed. 34 
Results: RDW was significantly greater in cats with HCM and CHF compared to cats with HCM without CHF and 35 
controls. RDW was also significantly associated with all-cause mortality in univariable survival analysis and this 36 
association remained significant in multivariable survival analysis after controlling for the effect of CHF, left 37 
atrial size, left ventricular systolic function, haematocrit and pro-thrombotic state.  38 
Conclusions: RDW increases may be seen in cats with CHF and is an independent predictor of all-cause death 39 
in cats with HCM without concurrent non-cardiac related illness. 40 
 41 
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Abbreviation: 46 
ATE Arterial Thromboembolism 
CBC  Complete Blood Count 
CHF Congestive Heart Failure 
HCM Hypertrophic Cardiomyopathy 
LVFS% Left ventricular fractional shortening 
Max LVWd  Maximal 2D end-diastolic left ventricular septal or free wall thickness 
LA:Ao Ratio of diastolic left atrial diameter to aortic root diameter 
RDW  Red Blood Cell distribution Width 
 47 
Introduction 48 
Red Blood Cell Distribution Width (RDW) is a measurement of the heterogeneity of red blood cell size 49 
distribution data and is routinely reported by automated haematology analysers.1 RDW is defined as the 50 
coefficient of variation of the red blood cell size; it has historically been used for the classification of anaemia. 51 
Recently, however, RDW has been correlated with prognosis in a variety of different human diseases, including 52 
acute and chronic heart failure,3-10 with an increase in RDW values associated with a decrease in survival time. 53 
The proposed mechanisms for the alteration of RDW in these patients include: inflammatory stress, nutritional 54 
deficiencies, impaired iron metabolism, inadequate production of erythropoietin, and the impact of 55 
comorbidities.8, 11, 12 56 
Hypertrophic cardiomyopathy (HCM) is the most common cardiac disease in cats, and several negative 57 
prognostic factors associated with decreased survival time have been identified, including the presence of: 58 
arterial thromboembolism, congestive heart failure, left atrial dilation, left ventricular and left atrial systolic 59 
dysfunction, extreme ventricular hypertrophy and elevation in cardiac biomarkers. 13-17 60 
RDW has been investigated in veterinary patients as an index of regenerative anaemia18, 19 and in dogs with 61 
mitral valve disease20 and pulmonary hypertension.b, 21  However, no association between RDW and outcome 62 
has been established in these studies. To date there have been no publications evaluating RDW as a prognostic 63 
indicator in feline patients. 64 
The aims of this study are to determine if RDW differs between healthy controls, cats with HCM and cats with 65 
HCM in congestive heart failure (CHF) and whether RDW values at presentation can provide useful prognostic 66 
information in feline patients with HCM. The hypothesis was that RDW would be higher in cats with HCM 67 
compared with the controls, and that higher RDW would be independently associated with cardiac death. 68 
 69 
Animals, materials and Methods 70 
The electronic medical record system of a veterinary teaching hospital was retrospectively searched for feline 71 
patients diagnosed with HCM between October 2006 and April 2013. Patients were selected if they had a full 72 
echocardiographic examination and haematology analysis submitted during the same visit or hospitalization 73 
period. Data collected from medical record included signalment, presenting clinical signs, physical examination 74 
findings, results of serum biochemistry, haematology analysis and thoracic radiographs when available. 75 
  76 
HCM was defined by two-dimensional echocardiography as an end-diastolic left ventricular wall thickness ≥ 6 77 
mm22, 23 on two-dimensional (2D) echocardiography in the absence of haemodynamic or metabolic causes of 78 
hypertrophy (such as systemic hypertension, fixed aortic stenosis, hyperthyroidism, acromegaly) based on 79 
appropriate tests performed during the diagnostic or treatment regime. Echocardiographic measurements 80 
were performed at the time of presentation to the clinic by a diplomate cardiologist or a cardiology resident 81 
under supervision and later reviewed by a single cardiologist (DJC). Data collected from echocardiography 82 
included maximal 2D end-diastolic left ventricular wall thickness (Max LVWd), ratio of left atrium to aortic root 83 
diameter (LA:Ao), left ventricular fractional shortening (LVFS%) and presence of spontaneous echo-contrast or 84 
a thrombus within the left atrium or auricular appendage. LA:Ao was measured from a 2D short axis view at 85 
the heart base, optimised for the left atrium and aortic valve, in the frame before aortic valve opening (end-86 
ventricular diastole) using an inner edge to inner edge technique.24 M-mode measurements LV fractional 87 
shortening (LVFS%) were made using a leading edge to leading edge method.16 Congestive heart failure was 88 
defined as present if the cat had radiographic or ultrasonographic evidence of cardiogenic pulmonary oedema 89 
or pleural effusion in the presence of left atrial dilation (LA:Ao ≥ 1.5)24 or tachypnoea responsive to furosemide 90 
in the presence of left atrial dilation (LA:Ao ≥ 1.5).24 If another potential cause of pleural effusion (e.g. 91 
intrathoracic neoplasia) was present the cat was excluded from the study. 92 
 93 
Arterial Thromboembolism (ATE) was defined as an acute onset of lower motor neuron deficits in one or more 94 
limbs associated with signs of regional hypoperfusion including pallor, cold extremities, and absence of 95 
peripheral pulses.25 96 
 97 
Due to the potential to affect the RDW value, patients were also excluded if they presented with concurrent 98 
systemic disease specifically neoplasia, endocrine, renal, inflammatory, infectious diseases or porto-systemic 99 
shunt; had evidence of recent blood loss or underwent surgical procedures or blood transfusions within the 100 
previous 3 months. This was established based on review of the history, physical examination, clinical 101 
progression, available laboratory and imaging findings and final diagnosis by the attending clinician.  102 
A single automated haematology analyser, Cell-Dyn 3500c routinely used in the Royal Veterinary College 103 
Diagnostic Laboratories for the analysis of feline haematology samples,26, 27 was used for all the RDW and 104 
haematocrit measurements. The Cell-Dyn 3500 reports a relative RDW equivalent to a coefficient of variation 105 
in percentage. The RDW is derived from the RBC histogram using the 20th and 80th percentiles. Quality 106 
control was performed on the Cell-Dyn 3500 every day and consisted of low, normal and high reference 107 
materials; if these materials were out of range, appropriate remedial action was taken. Haematology analyser 108 
histograms and blood smears were assessed for all patients at the time of the initial sample analysis. The 109 
assessment was performed by an experienced veterinary technician and reviewed by a board-certified or 110 
board eligible clinical pathologist, where abnormalities were identified according to the authors’ institution 111 
diagnostic laboratory protocols. For the purpose of the present study, all haematology reports were 112 
retrospectively reviewed and patients were excluded if they had a haematocrit <28% or poor separation of red 113 
blood cell and platelets populations on histograms was reported. Presence of platelet clumping on blood  114 
smear examination was noted. 115 
The study end-point was survival time associated with all-cause mortality. Cardiac mortality was defined as 116 
death or euthanasia due to clinical signs of CHF (i.e. worsening respiratory distress) or ATE, or sudden death 117 
unrelated to known systemic disease. Non-cardiac mortality was defined as death or euthanasia following 118 
clinical signs not related to cardiac disease. The end of the study period was the 1st of July 2014. Referring 119 
veterinarians were contacted to obtain missing follow-up data, using a protocol that conformed to good 120 
research practice policy at the authors’ institution. 121 
 122 
A control group was established with blood donor cats that underwent a full physical examination by either a 123 
cardiology or emergency and critical care diplomat and had a blood sample submitted for haematology 124 
analysis and serum biochemistry as part of their pre-donation screening. Controls were included if they had 125 
not donated in the previous 3 months, if no abnormalities were identified on medical history and physical 126 
examination and if results of haematology and serum biochemistry were unremarkable. Laboratory results 127 
were considered unremarkable if all parameters were within reference intervals, or, if outside these intervals, 128 
they were judged to be not clinically significant by 2 of the authors (GS, DJC). The controls were excluded if 129 
they had evidence of blood loss or underwent surgical procedures in the 3 months preceding the blood 130 
sample. Controls were also excluded if a murmur, gallop sound or arrhythmia was identified at the time of 131 
donation. 132 
Statistical analysis 133 
Normality of data was evaluated by visual inspection of histograms and the ShapiroeWilk test. Normally and 134 
non-normally distributed data were reported as mean (þ/ standard deviation) or as median (interquartile 135 
range), respectively. Differences between two groups of continuous data were tested with independent 136 
samples t-test for normally distributed data or the ManneWhitney U test for non-normally distributed data. 137 
Differences between more than two groups of continuous data were tested with one-way ANOVA for normally 138 
distributed data or a KruskaleWallis test for nonnormally distributed data. Post hoc, all pairwise comparisons 139 
were performed for statistically significant results and a Bonferroni correction was applied. Adjusted p-values 140 
are presented. Categorical variables were compared using a Chisquared test. Linear correlation between 141 
continuous variables was tested with Spearman’s rank correlation (ps). 142 
 143 
The median survival times and associated 95% Confidence Intervals (CI) were estimated via the KaplaneMeier 144 
method. Both univariable and multivariable time-to-event models were built and Hazard Ratios (HR) with CI 145 
were calculated using Cox Proportional Hazards Analysis. The end point of survival analysis was cardiac death, 146 
including both spontaneous death and euthanasia. For the purpose of survival analysis, each continuous 147 
variable was initially ranked in tertiles and assessed via the KaplaneMeier method: variables that presented an 148 
ordinal increase or decrease in survival for each tertile were evaluated in the univariable analysis as 149 
continuous. For variables that did not fit these criteria, a suitable cut-off was selected and they were assessed 150 
in the univariable analysis as categorical. Variables that had a significant association with outcome in the 151 
univariable analysis were carried forward in the multivariable analysis. The validity of the proportional hazard 152 
assumption was tested by visual assessment of the log minus log survival plots and scaled Schoenfeld 153 
residuals. Commercial statistical software was used to perform all the analyses.d Level of significance was set 154 
at 0.05. 155 
Results 156 
Seventy-three cats were eligible for inclusion between October 2006 and April 2013. Median (IQR) age on 157 
presentation was 5.78 (3.2-10.14) years. The majority of cats were male (77%), neutered (98%) and non-158 
pedigree (75%). Patients of 11 different pedigree breeds were included, with British Short Hair (n=4), Persian 159 
(n=3), Bengal (n=2) and Maine Coon (n=2) being the most represented breeds. On initial presentation 42/73 160 
(58%) cats were in CHF and 5/73 (7%) cats were diagnosed with ATE. Three cats had concurrent CHF and ATE. 161 
By June 2014 44/73 (60%) cats had died, 8/73 (11%) were alive and 21/73 (29%) were lost to follow up. 162 
Patients lost to follow-up or still alive at the end of the study period were right-censored for the purpose of 163 
survival analysis. Median (IQR) survival time was 188 (47-677) days, with a range of 0-2431 days. 164 
Platelet clumping was reported in 33/73 (45%) cats. Echocardiography identified evidence of spontaneous 165 
echo-contrast in 30/73 (41%) cats and a thrombus within the left atrium or left auricular appendage in 6/73 166 
(8%) cats.  167 
Thirty controls were included over the same period. Median (IQR) age of controls was 4.86 (3.17-5.86) years. 168 
The majority of controls were male (67%), neutered (90%) and non-pedigree (87%). Four pedigree breeds were 169 
represented among controls with one patient for each of the following: Bengal, Birman, Burmese and Maine 170 
Coon. 171 
For the initial statistical analysis 3 groups were compared: controls, cats with HCM without CHF (HCM non-172 
CHF) and cats with HCM and CHF (HCM+CHF). A summary of demographic, haematological and 173 
echocardiographic data for the 3 groups is presented in table 1. 174 
 175 
No statistically significant differences were present in sex (P = .363), breed (P = .327) or age (P = .224) between 176 
these 3 groups. A statistically significant difference was present in RDW between HCM+CHF and controls (P = 177 
.03) and between HCM+CHF and HCM non-CHF (P = .003) (figure 1). A statistically significant difference was 178 
also present in haematocrit between controls and HCM non-CHF (P = .005) (figure 2). No difference in the 179 
proportion of platelet clumping was present between the 3 groups (P = .094). To verify whether platelet 180 
clumps could affect RDW determination, RDW values of patients with and without platelet clumping were 181 
compared: no significant difference was identified (P = .235). 182 
 183 
Echocardiographic measurements were compared between HCM non-CHF and HCM+CHF groups. A 184 
statistically significant difference was present in LA:Ao (P = .006) and LVFS% (P = .016), but not in Max LVWd (P 185 
= .349).   186 
 187 
For the purpose of testing for correlations and survival analysis the controls were excluded and all HCM 188 
affected cats were evaluated together. The presence of ATE, left atrium or auricular appendage thrombus or 189 
spontaneous echo-contrast was analysed as a single categorical variable identifying a pro-thrombotic state. No 190 
significant difference was present in RDW between patients with and without a pro-thrombotic state (P = 191 
.094). 192 
 193 
Correlation between RDW and other continuous variables (Age, haematocrit, LA:Ao, Max LVWd and LVFS%) 194 
was tested. The only significant, although weak, positive correlation was present between RDW and Max 195 
LVWd (ρs correlation coefficient = .288, P = .014). 196 
 197 
Based on Kaplan-Meier curves RDW and LA:Ao appeared to have an ordinal decrease in survival for each 198 
tertile, therefore they were analysed as continuous variables (see an example in figure 3). Age, Max LVWd, 199 
LVFS% and haematocrit did not fulfil the requirements to be analysed as continuous variables, and were 200 
therefore transformed into dichotomous categorical variables. As cut-offs for Max LVWd and LVFS% we used 201 
≥9 mm and ≤30%, respectively. These cut-offs were selected based on their clinical relevance: they 202 
respectively define extreme hypertrophy and left ventricular systolic dysfunction and have been found to be 203 
independent predictors of decreased survival time in a recent study.16 The median patient age (5.78 years) was 204 
used as a cut-off for the age variable. The intermediate tertile for haematocrit (32.7% < haematocrit < 37.2%) 205 
appeared to be associated with a worse outcome compared to the upper and lower tertiles. The upper and 206 
lower tertiles were therefore pooled and used as a reference for comparison with the intermediate tertile.  207 
The results of the univariable survival analysis are summarized in table 2. Univariable predictors of increased 208 
risk of death were RDW, LA:Ao, CHF, left ventricular systolic dysfunction, pro-thrombotic state and an 209 
haematocrit between 32.7% and 37.2%. Age, sex, breed and extreme hypertrophy were not significantly 210 
associated with outcome in univariable analysis. 211 
 212 
The six variables that were significant in the univariable survival analysis were carried forward to multivariable 213 
survival analysis. Multivariable survival analysis was performed to ascertain if the association between RDW 214 
and increased risk of death would remain statistically significant after taking into account the effect of other 215 
control variables. Of the 6 predictor variables tested only RDW and LV systolic dysfunction remained 216 
statistically significant (Table 3). 217 
 218 
Discussion 219 
In this study RDW was significantly greater in HCM+CHF cats with compared to HCM non-CHF cats and control 220 
cats. However there was major overlap between the groups limiting its potential use as a diagnostic test 221 
especially when more established cardiac biomarkers such as cardiac troponin I and N-terminal pro-B type 222 
natriuretic peptide have proven efficacy.17, 28, 29 Of more clinical relevance however is our finding that RDW 223 
provides useful prognostic information since a greater RDW value at presentation was associated with a 224 
significantly higher risk of death in cats with HCM. This remained statistically significant following correction 225 
for the presence of congestive heart failure, pro-thrombotic state, systolic dysfunction, left atrial size or 226 
haematocrit. This shows that RDW remains an independent predictor of all-cause death in cats with HCM 227 
without concurrent non-cardiac illness, even when previously established and robust prognostic indicators are 228 
accounted for.16 Each single percentage point increase in RDW was associated with a 1.34 increase in the risk 229 
of death in our study population. To the authors’ knowledge this is the first study to report an association 230 
between RDW and prognosis in veterinary patients. Previous studies have investigated RDW in dogs with 231 
pulmonary hypertension and mitral valve disease, but failed to identify an association between RDW and 232 
outcome. 233 
 234 
These findings are in agreement with what has been reported in human patients, where RDW is an 235 
independent prognostic factor across a variety of conditions, including acute and chronic heart failure.3-10 The 236 
pathophysiology of this association has not been fully elucidated. Potential mechanisms that have been 237 
proposed to explain the relationship between RDW and heart failure include inflammatory stress, nutritional 238 
deficiencies, impaired iron metabolism, inadequate production of erythropoietin, and the impact of 239 
comorbidities such as liver and renal dysfunction.8, 11, 12 Most of these processes share common pathways with 240 
anaemia of chronic disease30 and anaemia of critical illness.31 RDW might therefore represent an integrative 241 
measure of different pathological processes occurring during heart failure and contributing to the clinical 242 
outcome. Given the practical difficulties associated with measuring these underlying processes, RDW has been 243 
proposed as a “barometer” of cardiovascular health that provides the sum of these multiple complex 244 
interactions.2, 8, 12 245 
 246 
Of note: RDW was not significantly different between control cats and cats with HCM non-CHF. A possible 247 
explanation is that in the context of HCM, RDW may be a late marker of severity that does not rise until the 248 
disease has reached a more advanced stage. However, this finding may also be influenced by insufficient 249 
statistical power due to the small sample size or choice of control population. The control population used in 250 
this study was formed of blood donor cats, and although cats had not donated for at least 3 months before 251 
blood sampling, an increase in RDW associated with previous blood donations could not be completely ruled 252 
out. Furthermore, although all control cats received a careful physical examination by either a cardiology or 253 
emergency and critical care diplomat only a small percentage of them had an echocardiogram performed at 254 
time of donation.  255 
Age, sex and breed distributions of our population were similar to that reported in previous studies.13-16 256 
However, the median (range) survival time for mortality in our population (188, IQR 47-677 days) was shorter 257 
than previously reported (709-1276 days).13-15 This probably reflects a higher percentage of patients in CHF in 258 
our population (58%) compared to previous reports (33-46%), 14-16 since the majority of the affected cats in 259 
this study were presented as emergencies. In our institution these cats are more likely to have a blood sample 260 
submitted for haematological analysis compared to asymptomatic cats presenting for a routine appointment. 261 
Interestingly the haematocrit values of the HCM non-CHF population were significantly lower than those of the 262 
controls. This might be associated with the development of anaemia of chronic disease or the effect of neuro-263 
humoral systems response to the cardiomyopathy causing an increase in circulating volume without overt CHF 264 
resulting in dilutional anaemia. The absence of a significant difference in haematocrit between controls and 265 
HCM cats in CHF may reflect the small sample size or the effect of treatments such as furosemide. 266 
 267 
This study contains numerous limitations mainly due to its retrospective nature. Different diagnostic and 268 
treatment protocols were used. Not all patients had thyroid hormone levels analysed to definitively rule out 269 
hyperthyroidism in the absence of a palpable goitre. The small population size limited the study statistical 270 
power and prevented the evaluation of the effect of other possible confounding variables such as treatment. 271 
Time from sample collection to processing could not be retrospectively evaluated and aging of the sample 272 
could have affected haematological variables.26 Follow-up data obtained by referring veterinarians were also 273 
inadequate to accurately classify patients’ cause of death or euthanasia as cardiac or non-cardiac. For this 274 
reason we elected to consider only all-cause mortality for the purpose of survival analysis. 275 
 276 
Only one haematology analysis and one echocardiographic examination were evaluated for each patient at the 277 
time of presentation. A progressive increase in RDW values over time is associated with a worse outcome in 278 
human heart failure and may provide additional information compared to a single determination.32 279 
Assessment of the prognostic value of RDW in cats with HCM at different time points during disease 280 
progression should be evaluated in future studies. 281 
 282 
The RDW values can vary depending on the analytical technique used to measure erythrocyte volume and the 283 
algorithm that calculates it based on the erythrocyte volume distribution data.33 Therefore, the results of the 284 
current studies cannot be generalised to RDW measured with different methodologies.  285 
 286 
Aggregation of platelets into large clumps is common in cats and may cause them to be counted as one large 287 
cell by automated haematology analyser,34 falsely altering haematological variables such as RDW. However, in 288 
our study population, RDW did not appear to be significantly affected by platelet clumping. All haematological 289 
analyses were performed with a Cell-Dyn 3500. Most of the human literature is based on the use of more 290 
modern haematology analysers that could provide better discrimination between different cell populations 291 
thus providing more accurate data. This would also permit us to better elucidate the role of platelet numbers 292 
and platelet clumping in the overall RDW determination. 293 
 294 
Conclusions 295 
Red blood cell distribution width is a simple, inexpensive and ubiquitously available laboratory parameter. 296 
Greater RDW values were independently associated with an increased risk of cardiac mortality in cats with 297 
HCM. Given the retrospective nature of this study and the small sample size, the results should be interpreted 298 
as a promising foundation for further prospective studies evaluating the clinical value of RDW as a prognostic 299 
indicator in this disease. 300 
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Footnotes 312 
a. Royal Veterinary College, Hawkshead Lane, Hatfield, Hertfordshire, UK, AL9 7TA; 313 
b. Poser H, Mazzotta E, Menciotti G, Contiero B, Baron Toaldo M, Guglielmini C. Red blood cell 314 
distribution width in dogs with pre-capillary and post-capillary pulmonary hypertension.  Poster 315 
presented at the American College of Veterinary Internal Medicine Forum, June 12-15 2013, Seattle, 316 
Washington; 317 
c. Cell-Dyn 3500 Abbot Abbott Laboratories, Abbott Park, Illinois, USA with system operator manual; 318 
d. IBM SPSS Statistics for Windows, Version 22.0, IBM Corp., Armonk, NY, USA. 319 
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Table legend 419 
Table 1: Comparison of demographic, haematological and echocardiographic data between controls, cats with 420 
hypertrophic cardiomyopathy without congestive heart failure (HCM non-CHF) and cats with hypertrophic 421 
cardiomyopathy and congestive heart failure (HCM + CHF). Data are presented as number present (%), Mean ± 422 
SD or Median (IQR). 423 
 Controls 
HCM(a) non-
CHF(b) HCM + CHF p-Value 
Number of cats 30 31 42 – 
Age, years (range) 4.9 (3.2–5.9) 6.0 (2.6–10.1) 5.7 (3.2–8.5) 0.224 
Male, n (%) 20/30 (67%) 22/31 (71%) 34/42 (81%) 0.363 
Non-pedigree, n 
(%) 26/30 (87%) 22/31 (71%) 33/42 (79%) 0.327 
RDW (c) % 
(range) 
19.2 (18.6–
20.6)** 
19.0 (18.3–
20.1)* 
20.3 (19.5–
22.6)* 0.002 
HCT (d) (%) 37.8 ± 4.3* 34.1 ± 3.9* 36.4 ± 4.8 0.006 
Platelet clumping, 
n (%) 17/30 (57%) 10/31 (32%) 23/42 (55%) 0.094 
Pro-thrombotic 
state, n (%) – 13/31 (42%) 24/42 (57%) 0.241 
LA:Ao (e) (range) – 
1.87 (1.29–
2.21) 
2.15 (1.84–
2.63) 0.006 
Max LVWd, (f) 
mm (range) – 
8.03 (7.20–
9.89) 
7.83 (6.48–
9.07) 0.349 
LVFS, (g) % 
(range) – 
46.5 (37.0–
59.0) 
40.0 (29.0–
48.2) 0.016 
* and **  indicate significant differences between groups following post hoc pairwise comparisons. 424 
a. Hypertrophic cardiomyopathy.  425 
b. Congestive heart failure.  426 
c. Red blood cell distribution width. 427 
d. Haematocrit. 428 
e. Left atrium to aortic diameter ratio. 429 
f. Maximal 2D left ventricular free or septal wall thickness. 430 
g. Left ventricular fractional shortening.  431 
Table 2: Results of univariable Cox proportional hazards analysis evaluating the association of individual 432 
variables with a shorter time to cardiac death. 433 
   
95.0% CI(a) for 
hazard ratio 
 p-Value 
Hazard 
ratio Lower Upper 
RDW(b)(%) 0.00006 1.346 1.164 1.557 
Age (years)    
 ≤5.8 Reference   
 >5.8 0.326 1.369 0.731 2.565 
Sex     
 Female Reference   
 Male 0.105 1.862 0.877 3.952 
Breed     
 Non-pedigree Reference   
 Pedigree 0.587 0.825 0.389 1.708 
CHF(c)     
 No Reference   
 Yes 0.022 2.095 1.112 3.947 
LA:Ao(d) 0.0003 2.303 1.458 3.637 
LVFS%(e)     
 >30% Reference   
 ≤30% 0.00001 4.744 2.353 9.562 
Max LVWd(f)    
 <9 mm Reference   
 ≥9 mm 0.967 1.015 0.496 2.078 
Pro-thrombotic state   
 No Reference   
 Yes 0.004 2.557 1.36 4.808 
Haematocrit    
 HCT(g) ≤32.7% and 
≥37.2% Reference   
 32.7% < HCT < 37.2% 0.005 2.441 1.315 4.532 
a. 95% Confidence Interval.  434 
b. Red blood cell distribution width.  435 
c. Congestive heart failure.  436 
d. Left atrium to aortic diameter ratio.  437 
e. Left ventricular fractional shortening. 438 
f. Maximal 2D left ventricular free or septal wall thickness. 439 
g. Haematocrit. 440 
  441 
Table 3: Results of multivariable Cox proportional hazards analysis using parameters identified as 442 
significant in the univariable analysis. 443 
   95.0% C(a) for hazard ratio 
 p-value Hazard ratio Lower Upper 
RDW (b)(%) 0.001 1.337 1.127 1.585 
 >30% Reference    
 ≤30% 0.0004 4.872 2.023 11.73 
LA:Ao (d) 0.714 1.147 0.549 2.396 
CHF (e)     
 No Reference    
 Yes 0.547 1.262 0.591 2.695 
Pro-thrombotic 
state     
 No Reference    
 Yes 0.099 1.753 0.901 3.414 
Haematocrit     
 HCT (f) ≤32.7% 
and ≥37.2% Reference    
 32.7% < HCT < 
37.2% 0.11 1.716 0.884 3.329 
 444 
a. 95% Confidence Intervals. 445 
b. Red blood cell distribution width.  446 
c. Left ventricular fractional shortening.  447 
d. Left atrium to aortic diameter ratio.  448 
e. Congestive heart failure.  449 
f. haematocrit. 450 
  451 
Figure captions 452 
Figure 1. Boxplot graph comparing Red Blood Cell Distribution Width (RDW) values between controls, cats with 453 
Hypertrophic Cardiomyopathy (HCM) without Congestive Heart Failure (CHF) and cats with HCM and CHF. * 454 
adjusted P value = .003; ** adjusted P value = .03. 455 
 456 
  457 
Figure 2. Boxplot graph comparing Haematocrit values between controls, cats with Hypertrophic 458 
Cardiomyopathy (HCM) without Congestive Heart Failure (CHF) and cats with HCM and CHF. * adjusted P value 459 
= .005. 460 
 461 
  462 
Figure 3. Kaplan-Meier curves to show differences in survival associated with each Red Blood Cell Width (RDW) 463 
tertile.  464 
 465 
